Precision Injection Molding: Supporting Primary Containment in Injectable Drug Delivery

In the dynamic landscape of healthcare, the demand for innovative solutions in injectable drug delivery has never been greater. As an experienced precision injection molding company, we are committed to pushing the boundaries of what’s possible in primary containment. In this technical post, we’re excited to share insights into how our expertise is reshaping the industry and driving the evolution of novel primary containment solutions. 


At PDC, we believe that precision is not just a capability but a commitment to excellence. With decades of experience in precision injection molding, we have honed our expertise to meet the evolving needs of the Injectable Drug Delivery market segment. Our focus on innovation, quality, and reliability positions us as a trusted partner for pharmaceutical companies seeking cutting-edge primary containment solutions. 

Innovative Products and Applications: 

  • Complex Container Geometry: Our advanced injection molding techniques enable the creation of unique container geometries that were once deemed unfeasible. By leveraging intricate designs, we offer pharmaceutical companies the opportunity to optimize drug stability, enhance compatibility, and improve patient convenience. From multi-faceted vials to uniquely shaped cartridges, our solutions empower our partners to stand out in a competitive market. 
  • Dual Chamber Containers: Recognizing the demand for dual-chamber containers for drug reconstitution and combination therapies, we have developed expertise in manufacturing precise and reliable dual-chamber systems. Our dual-chamber containers maintain the integrity of each drug component while ensuring accurate dosing and streamlined administration. With customizable options and rigorous quality control, we provide pharmaceutical companies with a platform to deliver innovative treatment modalities with confidence. 
  • Needleless Containers: As the demand for needleless injection devices continues to rise, we are at the forefront of developing needleless container solutions. By integrating innovative features such as self-sealing septa and integrated fluid pathways, our needleless containers offer enhanced safety, convenience, and usability for patients and healthcare professionals alike. High speed streams of fluid used in needleless injection devices require micro molded nozzle geometry. Whether for single-dose applications or multi-dose systems, our needleless containers redefine the standard for injectable drug delivery. 

Establishing Thought Leadership: 

At PDC, our commitment to thought leadership extends beyond product innovation. Through collaborative partnerships, ongoing research, and knowledge sharing initiatives, we strive to drive meaningful conversations and shape the future of injectable drug delivery. By engaging with industry stakeholders, sharing best practices, and addressing emerging challenges, we aim to foster a community dedicated to advancing patient care and improving outcomes. 

Insights and Key Considerations 

  1. Material Selection: The choice of material is paramount in precision injection molding for primary containment. It’s imperative to select materials that meet the stringent requirements of the pharmaceutical industry, including biocompatibility, chemical resistance, and dimensional stability. Moreover, considering the specific characteristics of the drug being delivered is crucial. Compatibility with the drug formulation, storage temperature, its pH, and any potential interactions are all factors that must be carefully evaluated during material selection. 
  2. Design for Manufacturability (DFM): Designing for manufacturability is vital to ensure the efficiency and cost-effectiveness of the injection molding process. Collaborating closely with design engineers and molders from the outset can help optimize the design for injection molding, thereby minimizing tooling costs, cycle times, and material waste. Features such as uniform wall thickness, adequate draft angles, and appropriate gating and venting are all considerations that contribute to successful injection molding of primary containment systems. Furthermore, incorporation of insert molding into container designs greatly improves manufacturability of staked needle syringes. Early collaboration among design and manufacturing engineers determines the success for scalable product launches. 
  3. Quality Assurance and Regulatory Compliance: In the pharmaceutical industry, adherence to regulatory standards and stringent quality control measures is imperative. Precision injection molding for primary containment applications demands rigorous quality assurance protocols throughout the manufacturing process. From material traceability and validation to in-process inspections and final product testing, every step must be meticulously documented and compliant with regulatory requirements such as the FDA’s Current Good Manufacturing Practice (cGMP) guidelines. Holding industry specific knowledge of USP 788 particulate counts and ISO 11608 Standards ensures product development teams receive experienced engineering support for product testing and validation. Incorporation of automated inspection vision systems allows manufacturing processes to maintain quality assurance with reduced inspection costs. 
  4. Lifecycle Management and Continuous Improvement: The landscape of injectable drug delivery is dynamic, with evolving regulatory requirements, technological advancements, and market demands. Therefore, embracing a proactive approach to lifecycle management and continuous improvement is essential for staying ahead in precision injection molding for primary containment. Regular assessments of manufacturing processes, materials, and designs enable manufacturers to identify opportunities for optimization, innovation, and adaptation to emerging trends, ensuring sustained competitiveness and customer satisfaction. 


As the Injectable Drug Delivery market continues to evolve, the importance of innovative primary containment solutions cannot be overstated. At PDC, we are proud to be at the forefront of this transformation, leveraging our expertise in precision injection molding to support the development of novel therapies and enhance patient well-being. Together with our partners, we look forward to shaping the future of injectable drug delivery and delivering on the promise of precision, reliability, and excellence.